Saturday, July 12, 2025

Latest

BofA Terminates Coverage On Tilray, Aurora Cannabis

On November 18th, Bank of America terminated coverage on Tilray Inc (TSX: TLRY) and Aurora Cannabis (TSX: ACB), citing a reallocation of resources while slashing their price targets on Canopy and Cronos. This comes after the licensed producers showed another weak quarter.

For the Tilray termination note, they add some colour going forward after the fiscal first quarter, saying that COVID sales headwinds are expected to persist. They believe this is the case since COVID-19 had impacted store sales, with Ontario opening their stores up again at full capacity just recently. They write, “COVID concerns are impacting the consumer behavior and weighing on traffic” and believe that the provinces are just starting to replenish their inventories.

Lastly, on Tilray, Bank of America believes Tilray will see the rest of the merger synergies into the second half of the company fiscal year. They note that Tilray realized $55 million of its targeted $80 million in merger synergies.

BofA also comments that Tilray saw $8 million in cash savings for the quarter, all in selling, general and administrative costs. They believe that about 30% of all synergies will flow through the cost of goods sold and write, “we assume a benefit starting in F2H now that the company has turned through legacy-Tilray inventory.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Tilray: Analysts Leave Targets Unchanged After MedMen Investment

On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited...

Thursday, August 19, 2021, 01:03:00 PM

Galaxy Digital: BMO Reiterates $44.00 Price Target After Fireside Chat

On December 17th, BMO Capital Markets hosted a fireside chat with Michael Novogratz and Chris...

Tuesday, December 28, 2021, 03:01:00 PM

Nutrien Sees Consensus Price Target Improvement Following Raised Guidance

On June 21st, Nutrien (TSX: NTR) raised their first half 2021 earnings per share guidance...

Wednesday, June 23, 2021, 03:36:00 PM

Columbia Care: Canaccord Reiterates Top Pick Following Green Leaf Medical Acquisition

Last Friday, Columbia Care Inc. (CSE: CCHW) closed their acquisition of Green Leaf Medical which...

Friday, June 18, 2021, 01:30:00 PM

Stifel: Comparing US Cannabis To Traditional CPG Suggests ~20x Upside

On Monday Stifel GMP released their 2021 US Cannabis outlook. Andrew Partheniou, Stifel GMP’s cannabis...

Wednesday, January 6, 2021, 10:48:00 AM